EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 30 (2023) Parasite, 30 (2023) 10 Full HTML
Open Access
Review

Table 2

List of peptides described in included studies.

Reference Peptide sequence Peptide name given by authors Antigen name ID UniProt (protein or gene name) or NCBI accession number of antigen
Bremer Hinckel, B.C. et al., 2019 [7] NIRIHLGDTIRIAPCK EpQ11 Transitional endoplasmic reticulum ATPase, putative LDBPK_361420
Carmelo, E. et al., 2002 [10] MFANSSAAAVTAASNSPQRS 23061 Histone H1 AF131892
SNSPQRSPRPSPKKAAVKKA 23063
KKAAAKKAAAKKAAPKKAAP 23065
KAAPKRAAPKRAAPKKAAPK 23067
APKKAAAKRAAKKSAPKKAV 23069
APKKAVKKAVKAAKKAVKKA 23071
AVKKAAKKATKRTAKKAAKK 23073
Carvalho, A.M.R.S. et al., 2018 [11] SGAPRANNSGDASA Peptide-1 Stabilization of polarity axis, putative LINJ_30_2730
GLSGEGSPASPEPRLAGGGGGADTQSTT Peptide-2
DGKPKENQKTARES Peptide-3 Hypothetical protein, conserved LINJ_32_0280
VADSGSASSEDGGSAKP Peptide-4
PRKADPNDTTPQ Peptide-5 MRP1 LINJ_27_0980
GDSPPSDSPQNNQDRNRNQN Peptide-6
Mix I peptides 2+3+6 Mix I Mix Mix
Mix II peptides 1+2+3+4+5+6 Mix II Mix Mix
Mix III peptides 2+6 Mix III Mix Mix
Mix IV peptides 3+6 Mix IV Mix Mix
Costa, L.E. et al., 2016 [15] ASFLKNR A10 ND ND
SSPFLFS B7
RSMEIDR B10
LEKVFSP C11
KFTLKAR C12
MKFTLNA H7
Costa, L.E. et al., 2017 [16] LSFPFPG B10 Peptide β-tubulin XP_001468164.1
FTSFSPY C01 Peptide
Costa, M.M. et al., 2012 [17] VGPQSVGPLSVGPQSVGPLS 47 A2 (amastigote stage-specific S antigen) ND
TPAVQKRVKEVGTKP 17 NH (Nucleoside hydrolase) ND
TTVVGNQTLEKVT 18
VVSTSRDGTAISWK 19 LACK (Leishmania analogue of the receptor kinase C) ND
ESTTAAKMSAEQDRESTRATLE 13 K39 (putative kinesin 39) ND
Mix peptides 13 + 19 Mix peptides 13 + 19 Mix Mix
Mix peptides 18 + 19 Mix peptides 18 + 19 Mix Mix
Mix peptides 13 + 47 Mix peptides 13 + 47 Mix Mix
Mix peptides 17 + 47 Mix peptides 17 + 47 Mix Mix
Mix peptides 19 + 47 Mix peptides 19 + 47 Mix Mix
Galvani N.C. et al., 2021 [26] KLTSMTPHEFKAICRL Pept1 Hypothetical protein LiHyT XP_001465138.1
RVQATEAQDRDLYARF Pept2
PELYQQYVDYYVMYYE Pept3 Hypothetical protein LiHyD XP_001468360.1
EPLLQQTQRAHMQRQQPAMPQPGYQPPPPM Pept4
SQGASSGTCANAKCIPGNT Pept5 Hypothetical protein LiHyV XP_001462854.1
SSFPITKGAALTVDYGRCE Pept6
EETIRRRHEQRAARVK Pept7 Hypothetical protein LiHyP XP_001468385.2
PRRLAAADLEELASAHEDFVAHLEKAKER Pept8
Galvani N.C. et al., 2022 [27] KLTSMTPHEFKAICRL Pept1 Hypothetical protein LiHyT XP_001465138.1
RVQATEAQDRDLYARF Pept2
PELYQQYVDYYVMYYE Pept3 Hypothetical protein LiHyD XP_001468360.1
EPLLQQTQRAHMQRQQPAMPQPGYQPPPPM Pept4
SQGASSGTCANAKCIPGNT Pept5 Hypothetical protein LiHyV XP_001462854.1
SSFPITKGAALTVDYGRCE Pept6
EETIRRRHEQRAARVK Pept7 Hypothetical protein LiHyP XP_001468385.2
PRRLAAADLEELASAHEDFVAHLEKAKER Pept8
Gonzales et al., 2002 [29] APKTAKKAAPKDVKATKVVKVT 23083 Ribosomal protein L25 AF131910
TKVVKVTTRKSYTRPQFRRPHTYRRPAIAKPS 23089
RPAIAKPSNRVTESKDITAF 23085
Link, J.S. et al., 2017 [35] GHRMPPTSVSALARP P1 GP63 XP_001562922.1
TMVPKEPNPLSGLRK P2
SKPQPNNFKLNSLGS P3
Mix P1+P2+P3 Mix P1+P2+P3
Machado, A.S. et al., 2020 [37] KWKTGAALDGAPQPLNTL PeptC Hypothetical protein LiHyC XP_001470432.1
Medeiros et al. 2022 [40] MNEPAPP peptide Tryparedoxin peroxidase LBRM.15.1100
Menezes-Souza, D. et al., 2014 [42] EEDESKKKSCGDEGEPKVE Peptide 1 HSP83.1 LBRM_33_0340
VTEGGEDKKK Peptide 2
EVAEAPPAEAAPA Peptide 3
Menezes-Souza, D. et al., 2015a [43] VGGGNSKNG Peptide-1 MAPK3 LBRM_10_0620
DPAEEADAP Peptide-2 MAPK4 LBRM_19_1710
Menezes-Souza, D. et al., 2015b [41] QTSGSTTPGPTTTT Peptide-1 CPB LBRM_08_0830
Oliveira-da-silva, J.A. et al., 2020a [47] AIREAKQKDHDHSDPTPDKATGSTK Peptide Pyridoxal kinase PK LINJ_30_1310
Oliveira-da-silva, J.A. et al., 2020b [48] EGVQEEDPTSLKNLFV PeptJ Hypothetical protein LiHyJ XP_001462647.1
Ramos F.F. et al., 2021 [58] TSKFWDT Pep1 Trypoanothione reductase and Tyrosine aminotransferase 2JK6_A and 4IX8_A
HITANES Pep2
LRINNQS Pep3 Trypoanothione reductase 2JK6_A
TTHTYFG Pep4 Trypoanothione reductase and Glyoxalase II 2JK6_A and 2P18_A
PAPSRMV Pep5 Glyoxalase II 2P18_A
DPSPWRQ Pep6 Tyrosine aminotransferase 4IX8_A
HRYSPSF Pep7 Trypoanothione reductase 2JK6_A
DPTTQYS Pep8 ND ND
SNYHSRW Pep9 Tyrosine aminotransferase 4IX8_A
Salles, B.C.S. et al., 2017 [62] FLCSHSN A3 ND ND
TFLFFPA A5
TFLVPLQ A8
RYVSVAS A11
FLSDVGE B2
TFFLRVR B9
INRSIKG H11
LIKISTK G12
Salles, B.C.S. et al., 2019 [63] MQKDEESGEFKCEL Peptide SMP-3 XP_003873457.1
Vale, D.L. et al., 2019 [69] LPFSISCVFASETRRLARERYGISG Peptide Amastin protein XP_003392700.1
Vale, D.L. et al., 2022 [70] IQFSDSIKRFNELDCE PepA Tryparedoxin XP_001563558.1
GFSGDSSESYSLSDNSSKVDDRIKL PepB Hypothetical protein XP_001568689.1
LVSIEDPFAEDNFDEF PepC Enolase XP_001563419.1
AFRISDPPQYSRVVPA PepD Hypothetical protein XP_001568689.1
IAKTLRDHGNGRYYLDSDSLYVN PepE Prohibitin XP_001568126.1
KGDATMKPERQASIE PepF Tryparedoxin XP_001563558.1
EIGSASKYGYSGWA PepG Enolase XP_001563419.1

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.